Articles Tagged With: FDA
-
Who Can Get the Janssen/J&J (Non-mRNA) COVID-19 Vaccine Now?
The Food and Drug Administration recently limited the use of the Janssen COVID-19 vaccine.
-
Now Is the Time to Change Label on Emergency Contraceptives
The FDA should change the labeling for levonorgestrel-based emergency contraception to reflect evidence-based knowledge that the drug does not act as an abortifacient, according to researchers. The label change is especially important now, as states are banning abortions and sometimes defining it in ways that would prohibit pharmacies from selling emergency contraception under its current FDA labeling. -
Feds Seek Comments on Mail-Back Program for Unused Opioids
Patients could use prepaid envelopes to safely return surplus pain pills.
-
FDA Struggles to Find Way Forward on COVID-19 Vaccine
Vaccine advisors to the Food and Drug Administration face a tight timeline and a host of unknowns as they try to prepare for an expected winter surge of COVID-19, all the while acknowledging that any plan forward could be dashed by the emergence of a new variant of the pandemic virus.
-
Reducing Barriers to Self-Managed Abortion Care
Self-managed abortion care could be far cheaper and easier to obtain than it is now in the United States, with legal barriers such as state laws banning mail-order abortion pills and the federal rule that still prevents pharmacies from selling mifepristone and misoprostol. -
FDA Approves Generic Treatment for COPD, Asthma
Agency aims to stimulate competition, expand access to cheaper meds.
-
Bebtelovimab Injection
The FDA has issued an emergency use authorization for a monoclonal antibody that demonstrated efficacy against the omicron variant of COVID-19.
-
Vaccine Expert: SARS-CoV-2 Is Becoming Endemic
Make of it what you will in an unpredictable pandemic, but one of the nation’s leading vaccine and immunology experts sees COVID-19 fading to a somewhat undefined endemic level and then returning as a seasonal virus next winter. -
Treatment Indication for Diabetes Drug Expanded to Include Heart Failure
FDA approves empagliflozin to help lower risk of hospitalization, death among heart failure patients.
-
AMA Asks to Remove Prescription Status from Naloxone
The request was made in the wake of a study that revealed expanded access to the opioid reversal agent is needed in almost every U.S. state.